nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—ABCC1—Dactinomycin—sarcoma	0.164	0.189	CbGbCtD
Saxagliptin—ABCC1—Mitoxantrone—sarcoma	0.147	0.17	CbGbCtD
Saxagliptin—ABCC1—Epirubicin—sarcoma	0.119	0.137	CbGbCtD
Saxagliptin—ABCC1—Vincristine—sarcoma	0.101	0.117	CbGbCtD
Saxagliptin—ABCC1—Etoposide—sarcoma	0.0926	0.107	CbGbCtD
Saxagliptin—ABCC1—Doxorubicin—sarcoma	0.0631	0.0729	CbGbCtD
Saxagliptin—CYP3A4—Thiotepa—sarcoma	0.0494	0.057	CbGbCtD
Saxagliptin—CYP3A5—Vincristine—sarcoma	0.0375	0.0433	CbGbCtD
Saxagliptin—CYP3A5—Etoposide—sarcoma	0.0343	0.0396	CbGbCtD
Saxagliptin—CYP3A4—Mitoxantrone—sarcoma	0.0212	0.0245	CbGbCtD
Saxagliptin—CYP3A4—Vincristine—sarcoma	0.0146	0.0169	CbGbCtD
Saxagliptin—CYP3A4—Etoposide—sarcoma	0.0134	0.0155	CbGbCtD
Saxagliptin—CYP3A4—Doxorubicin—sarcoma	0.00913	0.0105	CbGbCtD
Saxagliptin—DPP9—mammary gland—sarcoma	0.0082	0.0991	CbGeAlD
Saxagliptin—DPP8—myometrium—sarcoma	0.0053	0.064	CbGeAlD
Saxagliptin—DPP8—seminal vesicle—sarcoma	0.00479	0.0578	CbGeAlD
Saxagliptin—DPP8—smooth muscle tissue—sarcoma	0.00401	0.0484	CbGeAlD
Saxagliptin—DPP8—cardiac atrium—sarcoma	0.00345	0.0417	CbGeAlD
Saxagliptin—DPP9—tendon—sarcoma	0.00331	0.04	CbGeAlD
Saxagliptin—SLCO4C1—seminal vesicle—sarcoma	0.00303	0.0366	CbGeAlD
Saxagliptin—DPP8—tendon—sarcoma	0.00301	0.0364	CbGeAlD
Saxagliptin—DPP8—bone marrow—sarcoma	0.00292	0.0352	CbGeAlD
Saxagliptin—DPP9—testis—sarcoma	0.00274	0.0331	CbGeAlD
Saxagliptin—DPP9—liver—sarcoma	0.00259	0.0313	CbGeAlD
Saxagliptin—DPP8—testis—sarcoma	0.00249	0.0301	CbGeAlD
Saxagliptin—DPP8—liver—sarcoma	0.00236	0.0285	CbGeAlD
Saxagliptin—DPP4—embryo—sarcoma	0.00214	0.0259	CbGeAlD
Saxagliptin—DPP4—seminal vesicle—sarcoma	0.00201	0.0243	CbGeAlD
Saxagliptin—DPP9—lymph node—sarcoma	0.00199	0.024	CbGeAlD
Saxagliptin—DPP4—hematopoietic system—sarcoma	0.00191	0.0231	CbGeAlD
Saxagliptin—SLCO4C1—bone marrow—sarcoma	0.00185	0.0223	CbGeAlD
Saxagliptin—DPP4—connective tissue—sarcoma	0.00184	0.0222	CbGeAlD
Saxagliptin—DPP8—lymph node—sarcoma	0.00181	0.0218	CbGeAlD
Saxagliptin—DPP4—smooth muscle tissue—sarcoma	0.00168	0.0203	CbGeAlD
Saxagliptin—SLCO4C1—liver—sarcoma	0.00149	0.018	CbGeAlD
Saxagliptin—DPP4—uterus—sarcoma	0.00144	0.0174	CbGeAlD
Saxagliptin—DPP4—lymphoid tissue—sarcoma	0.00135	0.0163	CbGeAlD
Saxagliptin—DPP4—tendon—sarcoma	0.00126	0.0153	CbGeAlD
Saxagliptin—ABCC1—myometrium—sarcoma	0.00126	0.0152	CbGeAlD
Saxagliptin—SLC22A8—hematopoietic system—sarcoma	0.00126	0.0152	CbGeAlD
Saxagliptin—DPP4—bone marrow—sarcoma	0.00123	0.0148	CbGeAlD
Saxagliptin—ABCC1—seminal vesicle—sarcoma	0.00114	0.0137	CbGeAlD
Saxagliptin—Opportunistic infection—Epirubicin—sarcoma	0.00113	0.0219	CcSEcCtD
Saxagliptin—DPP4—testis—sarcoma	0.00105	0.0127	CbGeAlD
Saxagliptin—Opportunistic infection—Doxorubicin—sarcoma	0.00104	0.0203	CcSEcCtD
Saxagliptin—DPP4—liver—sarcoma	0.00099	0.012	CbGeAlD
Saxagliptin—Lymphopenia—Epirubicin—sarcoma	0.000887	0.0173	CcSEcCtD
Saxagliptin—CYP3A5—hematopoietic system—sarcoma	0.00083	0.01	CbGeAlD
Saxagliptin—Lymphopenia—Doxorubicin—sarcoma	0.000821	0.016	CcSEcCtD
Saxagliptin—ABCC1—cardiac atrium—sarcoma	0.000821	0.00991	CbGeAlD
Saxagliptin—ABCC1—uterus—sarcoma	0.000816	0.00986	CbGeAlD
Saxagliptin—Blood creatinine increased—Thiotepa—sarcoma	0.000767	0.0149	CcSEcCtD
Saxagliptin—DPP4—lymph node—sarcoma	0.000759	0.00917	CbGeAlD
Saxagliptin—ABCC1—tendon—sarcoma	0.000715	0.00864	CbGeAlD
Saxagliptin—Blood creatinine increased—Mitoxantrone—sarcoma	0.000662	0.0129	CcSEcCtD
Saxagliptin—Infestation NOS—Thiotepa—sarcoma	0.000631	0.0123	CcSEcCtD
Saxagliptin—Infestation—Thiotepa—sarcoma	0.000631	0.0123	CcSEcCtD
Saxagliptin—CYP3A4—hematopoietic system—sarcoma	0.000623	0.00753	CbGeAlD
Saxagliptin—ABCC1—testis—sarcoma	0.000592	0.00715	CbGeAlD
Saxagliptin—Erectile dysfunction—Vincristine—sarcoma	0.000578	0.0112	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.000568	0.0111	CcSEcCtD
Saxagliptin—Erectile dysfunction—Mitoxantrone—sarcoma	0.000563	0.011	CcSEcCtD
Saxagliptin—ABCC1—liver—sarcoma	0.00056	0.00676	CbGeAlD
Saxagliptin—Urinary tract infection—Mitoxantrone—sarcoma	0.000529	0.0103	CcSEcCtD
Saxagliptin—Immune system disorder—Thiotepa—sarcoma	0.000511	0.00995	CcSEcCtD
Saxagliptin—Sinusitis—Mitoxantrone—sarcoma	0.000511	0.00995	CcSEcCtD
Saxagliptin—Malnutrition—Thiotepa—sarcoma	0.000493	0.00959	CcSEcCtD
Saxagliptin—Infestation NOS—Etoposide—sarcoma	0.000453	0.00882	CcSEcCtD
Saxagliptin—Infestation—Etoposide—sarcoma	0.000453	0.00882	CcSEcCtD
Saxagliptin—CYP3A5—liver—sarcoma	0.00043	0.0052	CbGeAlD
Saxagliptin—ABCC1—lymph node—sarcoma	0.000429	0.00519	CbGeAlD
Saxagliptin—Myalgia—Thiotepa—sarcoma	0.00042	0.00817	CcSEcCtD
Saxagliptin—Arthralgia—Thiotepa—sarcoma	0.00042	0.00817	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000417	0.00811	CcSEcCtD
Saxagliptin—Myalgia—Dactinomycin—sarcoma	0.000416	0.00811	CcSEcCtD
Saxagliptin—Infection—Thiotepa—sarcoma	0.0004	0.00778	CcSEcCtD
Saxagliptin—Infection—Dactinomycin—sarcoma	0.000397	0.00772	CcSEcCtD
Saxagliptin—Thrombocytopenia—Thiotepa—sarcoma	0.000394	0.00767	CcSEcCtD
Saxagliptin—Thrombocytopenia—Dactinomycin—sarcoma	0.000391	0.00761	CcSEcCtD
Saxagliptin—Skin disorder—Thiotepa—sarcoma	0.000391	0.00761	CcSEcCtD
Saxagliptin—Myalgia—Vincristine—sarcoma	0.000372	0.00724	CcSEcCtD
Saxagliptin—Immune system disorder—Etoposide—sarcoma	0.000367	0.00715	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000366	0.00713	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000364	0.00708	CcSEcCtD
Saxagliptin—Arthralgia—Mitoxantrone—sarcoma	0.000362	0.00705	CcSEcCtD
Saxagliptin—Myalgia—Mitoxantrone—sarcoma	0.000362	0.00705	CcSEcCtD
Saxagliptin—Anaphylactic shock—Vincristine—sarcoma	0.000357	0.00694	CcSEcCtD
Saxagliptin—Infection—Vincristine—sarcoma	0.000354	0.0069	CcSEcCtD
Saxagliptin—Dyspepsia—Thiotepa—sarcoma	0.000354	0.00689	CcSEcCtD
Saxagliptin—Thrombocytopenia—Vincristine—sarcoma	0.000349	0.0068	CcSEcCtD
Saxagliptin—Anaphylactic shock—Mitoxantrone—sarcoma	0.000347	0.00676	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Thiotepa—sarcoma	0.000347	0.00676	CcSEcCtD
Saxagliptin—Fatigue—Thiotepa—sarcoma	0.000347	0.00675	CcSEcCtD
Saxagliptin—Infection—Mitoxantrone—sarcoma	0.000345	0.00672	CcSEcCtD
Saxagliptin—Fatigue—Dactinomycin—sarcoma	0.000344	0.0067	CcSEcCtD
Saxagliptin—Purpura—Epirubicin—sarcoma	0.000342	0.00666	CcSEcCtD
Saxagliptin—Thrombocytopenia—Mitoxantrone—sarcoma	0.00034	0.00662	CcSEcCtD
Saxagliptin—Hypoglycaemia—Epirubicin—sarcoma	0.000338	0.00657	CcSEcCtD
Saxagliptin—Skin disorder—Mitoxantrone—sarcoma	0.000337	0.00657	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Thiotepa—sarcoma	0.000329	0.0064	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Dactinomycin—sarcoma	0.000326	0.00635	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Vincristine—sarcoma	0.000325	0.00633	CcSEcCtD
Saxagliptin—CYP3A4—liver—sarcoma	0.000323	0.0039	CbGeAlD
Saxagliptin—Urticaria—Thiotepa—sarcoma	0.000319	0.00622	CcSEcCtD
Saxagliptin—Face oedema—Epirubicin—sarcoma	0.000318	0.00619	CcSEcCtD
Saxagliptin—Abdominal pain—Thiotepa—sarcoma	0.000318	0.00619	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000316	0.00616	CcSEcCtD
Saxagliptin—Purpura—Doxorubicin—sarcoma	0.000316	0.00616	CcSEcCtD
Saxagliptin—Abdominal pain—Dactinomycin—sarcoma	0.000316	0.00614	CcSEcCtD
Saxagliptin—Hypoglycaemia—Doxorubicin—sarcoma	0.000312	0.00608	CcSEcCtD
Saxagliptin—Blood creatinine increased—Epirubicin—sarcoma	0.000309	0.00601	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Vincristine—sarcoma	0.000308	0.00599	CcSEcCtD
Saxagliptin—Fatigue—Vincristine—sarcoma	0.000307	0.00599	CcSEcCtD
Saxagliptin—Dyspepsia—Mitoxantrone—sarcoma	0.000306	0.00595	CcSEcCtD
Saxagliptin—Fatigue—Mitoxantrone—sarcoma	0.000299	0.00583	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000299	0.00583	CcSEcCtD
Saxagliptin—Hypersensitivity—Thiotepa—sarcoma	0.000296	0.00577	CcSEcCtD
Saxagliptin—Nasopharyngitis—Epirubicin—sarcoma	0.000295	0.00574	CcSEcCtD
Saxagliptin—Face oedema—Doxorubicin—sarcoma	0.000294	0.00573	CcSEcCtD
Saxagliptin—Hypersensitivity—Dactinomycin—sarcoma	0.000294	0.00573	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Vincristine—sarcoma	0.000292	0.00568	CcSEcCtD
Saxagliptin—Gastritis—Epirubicin—sarcoma	0.000292	0.00568	CcSEcCtD
Saxagliptin—Anaphylactic shock—Etoposide—sarcoma	0.000289	0.00562	CcSEcCtD
Saxagliptin—Asthenia—Thiotepa—sarcoma	0.000289	0.00562	CcSEcCtD
Saxagliptin—Infection—Etoposide—sarcoma	0.000287	0.00559	CcSEcCtD
Saxagliptin—Asthenia—Dactinomycin—sarcoma	0.000286	0.00558	CcSEcCtD
Saxagliptin—Blood creatinine increased—Doxorubicin—sarcoma	0.000286	0.00556	CcSEcCtD
Saxagliptin—Pruritus—Thiotepa—sarcoma	0.000285	0.00554	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000284	0.00553	CcSEcCtD
Saxagliptin—Thrombocytopenia—Etoposide—sarcoma	0.000283	0.00551	CcSEcCtD
Saxagliptin—Abdominal pain—Vincristine—sarcoma	0.000282	0.00549	CcSEcCtD
Saxagliptin—Skin disorder—Etoposide—sarcoma	0.000281	0.00546	CcSEcCtD
Saxagliptin—Pancreatitis—Epirubicin—sarcoma	0.000279	0.00544	CcSEcCtD
Saxagliptin—Urticaria—Mitoxantrone—sarcoma	0.000276	0.00537	CcSEcCtD
Saxagliptin—Abdominal pain—Mitoxantrone—sarcoma	0.000275	0.00535	CcSEcCtD
Saxagliptin—Nasopharyngitis—Doxorubicin—sarcoma	0.000273	0.00531	CcSEcCtD
Saxagliptin—Gastritis—Doxorubicin—sarcoma	0.00027	0.00525	CcSEcCtD
Saxagliptin—Dizziness—Thiotepa—sarcoma	0.000266	0.00518	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Epirubicin—sarcoma	0.000265	0.00515	CcSEcCtD
Saxagliptin—Hypersensitivity—Vincristine—sarcoma	0.000263	0.00512	CcSEcCtD
Saxagliptin—Pancreatitis—Doxorubicin—sarcoma	0.000258	0.00503	CcSEcCtD
Saxagliptin—Hypersensitivity—Mitoxantrone—sarcoma	0.000256	0.00498	CcSEcCtD
Saxagliptin—Asthenia—Vincristine—sarcoma	0.000256	0.00498	CcSEcCtD
Saxagliptin—Vomiting—Thiotepa—sarcoma	0.000256	0.00498	CcSEcCtD
Saxagliptin—Infestation NOS—Epirubicin—sarcoma	0.000254	0.00494	CcSEcCtD
Saxagliptin—Infestation—Epirubicin—sarcoma	0.000254	0.00494	CcSEcCtD
Saxagliptin—Vomiting—Dactinomycin—sarcoma	0.000254	0.00494	CcSEcCtD
Saxagliptin—Rash—Thiotepa—sarcoma	0.000254	0.00494	CcSEcCtD
Saxagliptin—Dermatitis—Thiotepa—sarcoma	0.000253	0.00493	CcSEcCtD
Saxagliptin—Headache—Thiotepa—sarcoma	0.000252	0.00491	CcSEcCtD
Saxagliptin—Rash—Dactinomycin—sarcoma	0.000252	0.0049	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Etoposide—sarcoma	0.000249	0.00486	CcSEcCtD
Saxagliptin—Asthenia—Mitoxantrone—sarcoma	0.000249	0.00485	CcSEcCtD
Saxagliptin—Fatigue—Etoposide—sarcoma	0.000249	0.00485	CcSEcCtD
Saxagliptin—Urinary tract infection—Epirubicin—sarcoma	0.000247	0.0048	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000245	0.00477	CcSEcCtD
Saxagliptin—Nausea—Thiotepa—sarcoma	0.000239	0.00465	CcSEcCtD
Saxagliptin—Sinusitis—Epirubicin—sarcoma	0.000238	0.00464	CcSEcCtD
Saxagliptin—Nausea—Dactinomycin—sarcoma	0.000237	0.00462	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Etoposide—sarcoma	0.000236	0.0046	CcSEcCtD
Saxagliptin—Dizziness—Vincristine—sarcoma	0.000236	0.00459	CcSEcCtD
Saxagliptin—Infestation NOS—Doxorubicin—sarcoma	0.000235	0.00457	CcSEcCtD
Saxagliptin—Infestation—Doxorubicin—sarcoma	0.000235	0.00457	CcSEcCtD
Saxagliptin—Urticaria—Etoposide—sarcoma	0.00023	0.00447	CcSEcCtD
Saxagliptin—Abdominal pain—Etoposide—sarcoma	0.000228	0.00445	CcSEcCtD
Saxagliptin—Urinary tract infection—Doxorubicin—sarcoma	0.000228	0.00445	CcSEcCtD
Saxagliptin—Vomiting—Vincristine—sarcoma	0.000227	0.00441	CcSEcCtD
Saxagliptin—Rash—Vincristine—sarcoma	0.000225	0.00438	CcSEcCtD
Saxagliptin—Dermatitis—Vincristine—sarcoma	0.000225	0.00437	CcSEcCtD
Saxagliptin—Oedema peripheral—Epirubicin—sarcoma	0.000225	0.00437	CcSEcCtD
Saxagliptin—Headache—Vincristine—sarcoma	0.000223	0.00435	CcSEcCtD
Saxagliptin—Vomiting—Mitoxantrone—sarcoma	0.000221	0.0043	CcSEcCtD
Saxagliptin—Sinusitis—Doxorubicin—sarcoma	0.00022	0.00429	CcSEcCtD
Saxagliptin—Rash—Mitoxantrone—sarcoma	0.000219	0.00426	CcSEcCtD
Saxagliptin—Dermatitis—Mitoxantrone—sarcoma	0.000219	0.00426	CcSEcCtD
Saxagliptin—Headache—Mitoxantrone—sarcoma	0.000218	0.00424	CcSEcCtD
Saxagliptin—Hypersensitivity—Etoposide—sarcoma	0.000213	0.00414	CcSEcCtD
Saxagliptin—Nausea—Vincristine—sarcoma	0.000212	0.00412	CcSEcCtD
Saxagliptin—Oedema peripheral—Doxorubicin—sarcoma	0.000208	0.00404	CcSEcCtD
Saxagliptin—Asthenia—Etoposide—sarcoma	0.000207	0.00404	CcSEcCtD
Saxagliptin—Nausea—Mitoxantrone—sarcoma	0.000206	0.00402	CcSEcCtD
Saxagliptin—Immune system disorder—Epirubicin—sarcoma	0.000206	0.00401	CcSEcCtD
Saxagliptin—Pruritus—Etoposide—sarcoma	0.000204	0.00398	CcSEcCtD
Saxagliptin—Malnutrition—Epirubicin—sarcoma	0.000198	0.00386	CcSEcCtD
Saxagliptin—Flatulence—Epirubicin—sarcoma	0.000196	0.00381	CcSEcCtD
Saxagliptin—Dizziness—Etoposide—sarcoma	0.000191	0.00372	CcSEcCtD
Saxagliptin—Immune system disorder—Doxorubicin—sarcoma	0.00019	0.00371	CcSEcCtD
Saxagliptin—Vomiting—Etoposide—sarcoma	0.000184	0.00358	CcSEcCtD
Saxagliptin—Malnutrition—Doxorubicin—sarcoma	0.000184	0.00357	CcSEcCtD
Saxagliptin—Rash—Etoposide—sarcoma	0.000182	0.00355	CcSEcCtD
Saxagliptin—Dermatitis—Etoposide—sarcoma	0.000182	0.00354	CcSEcCtD
Saxagliptin—Headache—Etoposide—sarcoma	0.000181	0.00352	CcSEcCtD
Saxagliptin—Flatulence—Doxorubicin—sarcoma	0.000181	0.00352	CcSEcCtD
Saxagliptin—Nausea—Etoposide—sarcoma	0.000172	0.00334	CcSEcCtD
Saxagliptin—Arthralgia—Epirubicin—sarcoma	0.000169	0.00329	CcSEcCtD
Saxagliptin—Myalgia—Epirubicin—sarcoma	0.000169	0.00329	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000168	0.00327	CcSEcCtD
Saxagliptin—Anaphylactic shock—Epirubicin—sarcoma	0.000162	0.00315	CcSEcCtD
Saxagliptin—Infection—Epirubicin—sarcoma	0.000161	0.00313	CcSEcCtD
Saxagliptin—Thrombocytopenia—Epirubicin—sarcoma	0.000159	0.00309	CcSEcCtD
Saxagliptin—Skin disorder—Epirubicin—sarcoma	0.000157	0.00306	CcSEcCtD
Saxagliptin—Myalgia—Doxorubicin—sarcoma	0.000156	0.00304	CcSEcCtD
Saxagliptin—Arthralgia—Doxorubicin—sarcoma	0.000156	0.00304	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000155	0.00302	CcSEcCtD
Saxagliptin—Anaphylactic shock—Doxorubicin—sarcoma	0.00015	0.00292	CcSEcCtD
Saxagliptin—Infection—Doxorubicin—sarcoma	0.000149	0.0029	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000148	0.00287	CcSEcCtD
Saxagliptin—Thrombocytopenia—Doxorubicin—sarcoma	0.000147	0.00286	CcSEcCtD
Saxagliptin—Skin disorder—Doxorubicin—sarcoma	0.000146	0.00283	CcSEcCtD
Saxagliptin—Dyspepsia—Epirubicin—sarcoma	0.000143	0.00278	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Epirubicin—sarcoma	0.00014	0.00272	CcSEcCtD
Saxagliptin—Fatigue—Epirubicin—sarcoma	0.00014	0.00272	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000137	0.00266	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Epirubicin—sarcoma	0.000132	0.00258	CcSEcCtD
Saxagliptin—Dyspepsia—Doxorubicin—sarcoma	0.000132	0.00257	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000129	0.00252	CcSEcCtD
Saxagliptin—Fatigue—Doxorubicin—sarcoma	0.000129	0.00251	CcSEcCtD
Saxagliptin—Urticaria—Epirubicin—sarcoma	0.000129	0.0025	CcSEcCtD
Saxagliptin—Abdominal pain—Epirubicin—sarcoma	0.000128	0.00249	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000123	0.00239	CcSEcCtD
Saxagliptin—Hypersensitivity—Epirubicin—sarcoma	0.000119	0.00232	CcSEcCtD
Saxagliptin—Urticaria—Doxorubicin—sarcoma	0.000119	0.00232	CcSEcCtD
Saxagliptin—Abdominal pain—Doxorubicin—sarcoma	0.000118	0.00231	CcSEcCtD
Saxagliptin—Asthenia—Epirubicin—sarcoma	0.000116	0.00226	CcSEcCtD
Saxagliptin—Pruritus—Epirubicin—sarcoma	0.000115	0.00223	CcSEcCtD
Saxagliptin—Hypersensitivity—Doxorubicin—sarcoma	0.00011	0.00215	CcSEcCtD
Saxagliptin—Asthenia—Doxorubicin—sarcoma	0.000108	0.00209	CcSEcCtD
Saxagliptin—Dizziness—Epirubicin—sarcoma	0.000107	0.00208	CcSEcCtD
Saxagliptin—Pruritus—Doxorubicin—sarcoma	0.000106	0.00206	CcSEcCtD
Saxagliptin—Vomiting—Epirubicin—sarcoma	0.000103	0.002	CcSEcCtD
Saxagliptin—Rash—Epirubicin—sarcoma	0.000102	0.00199	CcSEcCtD
Saxagliptin—Dermatitis—Epirubicin—sarcoma	0.000102	0.00199	CcSEcCtD
Saxagliptin—Headache—Epirubicin—sarcoma	0.000101	0.00198	CcSEcCtD
Saxagliptin—Dizziness—Doxorubicin—sarcoma	9.91e-05	0.00193	CcSEcCtD
Saxagliptin—Nausea—Epirubicin—sarcoma	9.62e-05	0.00187	CcSEcCtD
Saxagliptin—Vomiting—Doxorubicin—sarcoma	9.53e-05	0.00185	CcSEcCtD
Saxagliptin—Rash—Doxorubicin—sarcoma	9.45e-05	0.00184	CcSEcCtD
Saxagliptin—Dermatitis—Doxorubicin—sarcoma	9.44e-05	0.00184	CcSEcCtD
Saxagliptin—Headache—Doxorubicin—sarcoma	9.39e-05	0.00183	CcSEcCtD
Saxagliptin—Nausea—Doxorubicin—sarcoma	8.9e-05	0.00173	CcSEcCtD
